About the Firm Portfolio Companies News & Events Contact Us   Home

09/19/2008 Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin® for the Treatment of Multiple Sclerosis Tovaxin Shows Favorable Annualized Relapse Rate and Excellent Safety Profile     09/11/2008 Top-Line Data from Opexa’s Phase IIb Tovaxin® Study to be Presented at World Congress on Treatment and Research in Multiple Sclerosis Novel T-Cell Vaccine Being Evaluated as Patient-Specific Treatment for MS     09/03/2008 Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program Collaboration to Identify Therapeutically Relevant Biomarkers and Offer Key Insight for Further Clinical Development of Tovaxin®     08/20/2008 Fairway Medical Technology to Develop BioSensor for Blood Pathogens and Warfare Threats Navy contract aims for real-time laboratory-quality capabilities in rugged battlefield instrument     08/19/2008 Kryptiq Acquires Secure Network Solutions Automatic Appointment Reminders and Billing Statements Strengthen Connect IQ™ Platform